Shares in one U.S. biotech firm have fallen more than 30% since late June, compared with a 0.1% decline in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE